Ironwood Pharmaceuticals, Inc. Class A Common Stock (I76)
FSX
Closed
Oct 9, 2026
Day's Range
3.3252 wk Range
1.21Overview - I76 - Ironwood Pharmaceuticals, Inc. Class A Common Stock
Key Statistics
Valuation
Enterprise Value
734.05M
P/E (Trailing)
‪4.72‬
P/E (Forward)
‪1.89‬
PEG Ratio
‪0.04‬
Price / Sales (TTM)
‪1.32‬
Price / Book
‪-3.18‬
EV / EBITDA
‪3.47‬
Profitability
Profit Margin
‪33.35%‬
Operating Margin
‪70.15%‬
Return on Assets
‪47.02%‬
Return on Equity
‪-9.17%‬
Ownership
Shares Outstanding
165.23M
Float
136.75M
Held by Insiders
‪3.23%‬
Held by Institutions
‪98.88%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪3.49‬
200-Day Avg
‪3.35‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - I76 - Ironwood Pharmaceuticals, Inc. Class A Common Stock
Peers - I76 - Ironwood Pharmaceuticals, Inc. Class A Common Stock
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- I76FSXIronwood Pharmaceuticals, Inc. Class A Common Stock518.85MMarket Cap+55.10%52-week change4.73P/E (Trailing)‪33.35%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation109.81BMarket Cap+26.04%52-week change35.40P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA60.08BMarket Cap+13.03%52-week change25.79P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR58.69BMarket Cap+14.60%52-week change24.77P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG39.87BMarket Cap-1.16%52-week change54.63P/E (Trailing)‪14.57%‬Profit Margin
- 0BOFSXJiangsu Hengrui Pharmaceuticals Co., Ltd.37.83BMarket Cap-75.44%52-week change37.67P/E (Trailing)‪24.93%‬Profit Margin
Profile Summary - I76 - Ironwood Pharmaceuticals, Inc. Class A Common Stock
About
Ironwood Pharmaceuticals, Inc. Class A Common Stock represents ownership in Ironwood Pharmaceuticals, Inc., a biotechnology company focused on developing and commercializing therapies for gastrointestinal disorders and rare diseases. Its current business centers on human therapeutics, with an emphasis on medicines for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
